Pegasus Laboratories, Inc. is recalling 81 cases (972 bottles) of Rebalance (sulfadiazine and pyrimethamine) Antiprotozoal Oral Suspension. The recall was initiated because the medication failed stability testing, showing inconsistent and low levels of the active ingredient pyrimethamine across the batch. The affected 946.4 mL (One Quart) bottles were distributed to distributors in Missouri and Florida.
Low or non-uniform levels of the active ingredient may result in the medication being less effective than intended for treating protozoal infections in animals. While no adverse events have been reported, inconsistent dosing can lead to treatment failure.
You have 2 options:
NADA# 141-240; Recall #: V-0058-2025
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response